Terms ending in 2035
Every in-force patent on Bionomics Limited's record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,546,214 | Humanized Antibodies That Bind LGR5 In force · High confidence | Carina Biotech Limited | In force | High confidence | |
| US 9,631,024 | Antibodies That Bind LGR4, Their Use in Inhibiting Neoplastic Cells and in Treating Tumors In force · High confidence | Bionomics, Inc. | In force | High confidence | |
| US 10,358,500 | Humanized Antibodies That Bind LGR5 In force · Medium confidence | Carina Biotech Limited | In force | Medium confidence |
3 of 3 patents shown. Soonest term end first, then patent number.
1 of these is in force and held by Bionomics Limited.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.